Contamination of oral pharmaceuticals with microorganisms may lead to deleterious effects on the therapeutic properties of the drug, and may potentially cause injuries to intended recipients. Thirty contaminated samples were detected representing 2% out of 1500 total collected samples. Out of 30 contaminated samples, only six samples (20%) revealed the presence of Clostridium perfringens. The biofilm assay was performed using the Microtiter Plate Method (MTP) for the six of the detected C. perfringens were three isolates biofilm forming. PCR multiplex was done for C. perfringens showed the presence of alpha toxin gene among all species. In spite of the current recommendation for a conventional detection method for Closterium spp., the application of multiplex PCR showed to be more, effective and able to detect Clostridium toxins genes.
INTRODUCTION
The use of contaminated pharmaceutical products has proved hazardous to the health of users. Contamination with microorganisms may lead to deleterious effects on the therapeutic properties of the drug (Coker, 2005) . Several factors can influence the microbiological quality of the non-sterile pharmaceutical products like; nature and origin of the material, the technique of production which may lead to the potential for microbial contamination (USP, 2018; BP, 2018). The microflora in the final product may represent contaminants from the raw materials, the equipment used, persons handling the product or from the container used for packaging (Denyer and Baird, 2007) .
Non-sterile oral medications contaminated with microflora are warning of the making risk to public health measures, particularly when exceeding the acceptable limit of >10 2 CFU/g or ml (USP, 2018). Moisture and high amount of sugar in the oral liquid drugs, in particular, can support the microbial growth. These microbial contaminations may ultimately contribute to secondary bacterial infections in pediatric patients (Cabañas Poy et al., 2016) . Even a few numbers of opportunistic pathogens may become infectious in patients with the severe underlying disease or immunocompromised (Mugoyela and Mwambete, 2010) . In addition, the presence of pathogenic or opportunistic microorganisms or bacterial toxic metabolites and enzymatic activity can result in the inactivation of the product (Gimenez-Bastida et al., 2018) .
Pharmacovigilance (PhV) has been defined by the World Health Organization (WHO,2004) as activities are done to monitor detection, assessment, understanding, and prevention of any obnoxious adverse reactions to drugs at a therapeutic concentration in animals and humans (Ibrahim et al., 2016) . As part of Good Manufacturing Practices (GMP), the United States Pharmacopoeia (USP) Microbial Limits Test provides methods for determining the safety of a product through the absence of indicator microorganisms, which can be considered a hazard to consumers and indicative of contamination. For this purpose, the USP specifies 5 bacterial indicators: Salmonella spp., Staphylococcus aureus, Pseudomonas aeruginosa, Escherichia coli and Clostridia (USP, 2018).
Clostridia species are members of normal intestinal and are ubiquitous in soil. They are Gram-positive spore-forming bacilli that are responsible for up to 10% of anaerobic infections with a wide range of clinical sites. Several species have been described (C. perfringens, C. novyi, C. septicum, C. bifermentans, C. sordellii, etc.) , among which C. perfringens has been reported to be the most frequent cause of gas gangrene (Bryant and Stevens, 2010; Stevens et al., 2012) . The virulence of this Gram-positive, spore-forming anaerobe is largely attributable to its ability to produce at least 17 different toxins (McClane et al., 2006) . However, there is considerable variability in the toxin armamentarium of different C. perfringens strains, which provides the basis for a toxinotyping classification system that divides C. perfringens isolates into five types (A-E) depending upon their ability to produce alpha, beta, epsilon, and iota toxin The presence of biofilm constitutes a major factor in the ability of the organism to resist the external unfavorable condition facilitating its growth and survival. (Gad et al., 2011) mentioned that preservative effectiveness might have been modulated by changes in microbial cell envelope and glycocalyx; furthermore, the presence of slime layer under conditions of limited nutrition may promote micro-colonization and formation of biofilm with significant resistance to antimicrobial agents (Craven et al., 1981) . Also, preservative availability may decrease by the interaction with packaging material or by volatilization during opening and closing of containers; hence, preserved medicines should be packed in sealed, impervious containers during storage (Denyer et al.,2004) .
The aim of this study was to determine the prevalence of Clostridium species in oral non-sterile pharmaceutical products investigated at National Organization for Drug Control & Research (NODCAR) and to detect toxin typing genes by the multiplex Polymerase Chain Reaction (PCR). 
MATERIALS AND METHODS

Nutrient agar
Sample collection and preparation
Samples were collected from Oct. 2016 till Nov. 2017 from pharmaceutical products delivered at NODCAR laboratories. Under aseptic conditions, a sample was taken using sterile tools and sterile containers. The sample container was labeled in details. Microbial enumeration tests were done with a Total viable aerobic count for all collected samples. Also, for monitoring the safety of non-sterile pharmaceutical preparations, the USP microbial limit tests require the absence of the following species; Salmonella spp., Staphylococcus aureus, Pseudomonas aeruginosa, Escherichia coli, Clostridia and Candida albicans. Tests for specified microbial contaminants were conducted according to the United States Pharmacopeia, USP40 (USP, 2018). A total number of 1500 of nonsterile samples comprised into different available classes of preparations including 406 syrup, 530 tablets,169 suspensions, 30 oral drops, 25 oral gel,320 capsules and 20 mouthwash which included locally manufactured and imported products were collected and examined for Total viable aerobic count.
Samples were prepared by dissolving or diluting 10g or 10ml of product in 90ml Soybean-casein digests broth (SCD) to make 100ml prepared sample of (1:10) dilution as described in the (Microbiological Examination of non-sterile products) (USP, 2018). The samples were mixed thoroughly in a rotatory shaker for the time period of 15 min at a speed of 120 rpm. To verify testing conditions, a negative control was performed using the chosen diluents in place of the test preparation and a reference strain C. sporogenes ATCC-11437 was used as a standard reference.
Isolation and identification of Clostridia spp.
Since May 2009 some changes in chapter 62 in USP was done about clarification of Clostridia test, therefore our research focused on the detection of this particular contaminant. The sample prepared in SCD broth was incubated at 37°C for 24h. The sample was divided into two portions of at least 10 ml then one of the portions was heated at 80°C for 10 min and cooled rapidly while the other portion set without heat. One milliliter aliquot of the sample in SCD broth of both portions was inoculated in the reinforced medium for Clostridia. The broth was incubated under anaerobic conditions at 35°C for 48 h. Subsequently, a loopful of each broth tube were separately streaked onto the surface of Columbia blood agar plate and incubated under anaerobic conditions using Oxoid ThermoFisher Scientific Jar System with BR0055 AneroGen indicator, incubation was done at 30 to 35°C for 48 -72 h. The occurrence of anaerobic growth of rods (with or without endospores) with negative catalase reaction indicated the presence of Clostridia. The presumed positive isolates were then confirmed by biochemical tests.
Biochemical tests
Identification of the potential bacteria was carried out using several biochemical tests. 
Spore Staining
Spore Stain (Schaeffer-Fulton Method) is a technique designed to isolate endospores by staining with malachite green, and any other vegetative cells with safranin as mentioned by Cappuccino and Sherman (2014).
Detection of some virulence factors
1-Biofilm assay for Clostridium perfringens
Clostridium perfringens was grown anaerobically on Reinforced Clostridial Agar or in fluid thioglycollate medium at 37°C.
Microtiter Plate Method (MTP) was performed according to Vidal et al. (2015) . Strains diluted of (1:10) were inoculated into fluid thioglycolate medium (FTG) and grown overnight at 37°C to produce biofilms. Although FTG free of cells was added to three wells of a sterile 96-well flat-bottomed plastic tissue culture plate and incubated at 37°C under anaerobic conditions. Biofilm was washed three times with phosphate-buffered saline (PBS) and then allowed to dry for 15 min. Crystal violet (0.4%) was then added, and the biofilms were incubated for 15 min and washed with deionized water to remove excess dye. After washing, crystal violet-stained biofilms were further dried at room temperature for 15 min. To quantify biofilm biomass, crystal violet was removed by adding 33% acetic acid solution. The Optical density (OD) of stained adherent bacteria was determined with a microplate reader (Biotech ELX 800 Power Wave Xs, USA) at a wavelength of 570nm (OD570). Each strain occupied three wells, and negative controls (media blanks) were included in at least 6 wells. All experiments were repeated three times.
For a comparative analysis of biofilm assay in MTP results, the adherence capability of the bacteria was classified into four categories: nonadherent, weakly adherent, moderately adherent and strongly adherent, based upon the ODs of the bacterial films (Stepanovic et al., 2000) .
2-Detection of four characterization toxin genes of C. perfringens by multiplex PCR DNA extraction
Selected isolates were subjected for toxin investigation as a virulence factor. To extract template DNA from C. perfringens for multiplex PCR, pure colonies were grown overnight in 5ml brain heart infusion at 37°C for 24h anaerobically. Then a rapid boiling procedure was used to prepare DNA template from C. perfringens according to Sheedy et al. (2004) .
Multiplex PCR of C. perfringens by four characteristic genes
The multiplex PCR assay was used to detect the presence of genes encoding alphatoxin (cpa), beta-toxin (cpb), epsilon-toxin (etx) and iota-toxin (iap). Primer sequences were reported by Van Asten et al. (2009) and illustrated in table 1. The protocol of amplification was performed as follows: 12.5 μl of 2× Green PCR master mix (DreamTaq™, Fermentas, Thermo scientific, USA), 4 μl DNA template, 0.5 μM of each primer (10 pmol/μl) then add PCR-grade water up to 25μl total reaction volume. The PCR reactions were performed using a Biometra PCR thermal cycler, Germany, with an initial denaturation at 94 °C for 3 min, followed by 35 cycles of, denaturation at 94°C for 1min, annealing at 55°C for 1min then extension at 72°C for 1 min and the final extension was at 72°C for 10 min (Van Asten et al., 2009) . The amplified samples were then analyzed by agarose gel electrophoresis using 1.5 % agarose gels (Fischer, Scientific®, UK)containing 0.5X TBE and prestained with ethidium bromide (Fischer Scientific, Canada). Electrophoresis was done at 70v for 60min in the presence of 100bp DNA ladder (Fermentas Life Science, EU) according to Sambrook et al. (1989) . A negative control PCR mixture with no template DNA was included. 
RESULTS
Our results indicated that thirty samples (2%) out of total 1500 samples were over microbial limit 10 2 CFU/g or /ml according to the USP 40 specified acceptance criteria of a total viable count for non-sterile products. Accordingly, table (2a) illustrates that 30 different trade products (10 syrups, 2tablets, 4capsules,12 suspensions and 2 oral drops) were found to exceed the specified limits. Only six contaminated products were rejected for indicator pathogens, according to the recommended criteria of oral pharmaceutical products in the USP. Also, microbial contaminants recovered from different collected dosage forms of oral pharmaceutical samples were illustrated in (table2b). As continuing to our investigation for detecting the Clostridia. Six samples were recovered with Clostridia spp. (20%) out of 30 contaminated samples (table 3) . Those samples were in classified form as four syrups, one oral drop and one capsule. Following their isolation, the Clostridia spp. were subjected to biochemical identification as illustrated in and confirmed identity by Vitek2 identification systems ANC ID card. Those six species were selected for further toxins detection as a virulence factor using multiplex PCRmethod. Table (4) illustrates the detection of biofilm formation among the six C. perfringens strains. Our results indicated that three strains had the ability to produce biofilm. One sample of C. perfringens in oral drops vivid a moderate biofilm formation followed by two weak biofilm formation represented in syrup products with different batch number. However, the least three batches revealed a non-adherent biofilm. The calculation was done as the Cut off was equal to 0.082512(mean of sterile medium + 3 SD). Performing PCR with four sets of specific primers for detecting the presence of α, β, ε, and ι encoding genes of C. perfringens. The fragment of 324 bp belonging to the α toxin gene was detected in all samples. While β, ε and ι encoding genes were not represented among the six C. perfringens.
DISCUSSION
Our results vivid that six C. perfringens were detected among 30 contaminated pharmaceuticals with four different brands this was consistent with a study done by Ashour et al. (1989) on 36 of talcum powder examined for anaerobic bacteria and they mentioned that the count of more than 100 CFU/g was not obtained from any product examined in the survey. However, qualitative tests for the presence of Clostridium spp. were carried out by conventional methods resulted in one of each brand contained C. perfringens and two samples from the third brand. El-Houssieny et al. (2013) investigated the microbial contaminant in non-sterile pharmaceuticals over 280 samples and they reported that Grampositive rods spore-bearers were the most commonly isolated bacteria from oral and topical medicaments and the tested oral preparations showed a higher incidence of contamination (33.75%) in comparison to the topical preparations (19.1%). Also, these findings were consistent with those of previous studies, where the majority of microbial contaminants in non-sterile pharmaceuticals are Bacillus spp. (Mwambete,2010 and Al-Charrakh ,2012). Gad et al. (2011) reported that a total number of 300 nonsterile pharmaceutical samples were tested for microbial contamination and all the tested samples were free from anaerobic bacteria, coliforms, and P. aeruginosa. Bacterial counts in the samples indicate that only syrups and suspensions had counts greater than 1000 CFU/ml.
In a related work,
In contrast to our results,
Our results revealed the incidence of three C. perfringens capable to form biofilm this was agreed by Varga et al. (2008) and Charlebois et al. (2014) who reported that the atmospheric oxygen tolerance assays showed that the biofilm could protect C. perfringens cells from oxygen stress. Moreover, oxidative stress resistance and the general stress response might be important for the development of biofilms in C. perfringens (Charlebois  et al., 2016) .
Alpha-toxin (cpa) was present in the six C. perfringens isolates in our study. Hence, the importance of its existence is consistent with many previous studies as well as Vidal et al. (2015) mentioned that alpha-toxin (cpa) may help in the building of C. perfringens biofilms and incorporated into the matrix, where it was seen partially colocalizing with extracted DNA. Moreover, Smedley et al. (2004) had stated that C. perfringens is a major cause of enteric diseases due to the production of several toxins. al. (2014) mentioned that C. perfringens biofilms if formed in vivo, are able to produce toxins that may participate in virulence and produce spores that may promote new infections and may be involved in environmental adaptation and resistance, virulence and spreading. This was consistent with several studies done by Rood and Cole (1991); Rood (1998) and Bryant (2003) stated that C. perfringens type A produces nearly 90% of all gas gangrene cases.
Pantaléon et
Generally, the presence of potentially pathogenic opportunistic microbes, cannot be overemphasized, because they may cause a significant deterioration in the health status of patients, particularly in elderly, debilitated and chronically sick patients, those who are
